Raymond James Financial’s SI-BONE Inc SIBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$636K Sell
50,356
-18,212
-27% -$285K ﹤0.01% 4188
2025
Q4
$1.35M Sell
68,568
-27,655
-29% -$480K ﹤0.01% 3580
2025
Q3
$1.42M Sell
96,223
-70
-0.1% -$1.14K ﹤0.01% 3437
2025
Q2
$1.81M Buy
96,293
+9,291
+11% +$154K ﹤0.01% 3156
2025
Q1
$1.22M Sell
87,002
-918
-1% -$14.8K ﹤0.01% 3345
2024
Q4
$1.23M Buy
+87,920
New +$1.18M ﹤0.01% 3310

Other funds holding SIBN

Raymond James Financial's SIBN Position: Q1 2026 in Review

Raymond James Financial reduced its SI-BONE Inc (SIBN) stake by 27% in Q1 2026, selling an estimated $285K and leaving 50,356 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #4188.

Raymond James Financial first reported a position in SIBN in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.81M in Q2 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

  • Raymond James Financial held 50,356 shares of SI-BONE Inc worth $636K as of Q1 2026.
  • Raymond James Financial sold 18,212 SI-BONE Inc shares in Q1 2026, an estimated $285K.
  • SI-BONE Inc made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4188 holding.
  • Raymond James Financial first reported a position in SI-BONE Inc in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's SI-BONE Inc position peaked at $1.81M in Q2 2025.
  • 180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.